tirzepatide surpass 5 SURPASS-2 (NEJM 2021) was the definitive head-to-head: vs semaglutide 1.0 mg (the maximum approved T2DM dose) in 1,879 patients with type 2 diabetes. All three tirzepatide doses produced superior HbA1c reductions Latest Data From SURPASS Trials

These medications have not been tested in people without obesity or diabetes, nor do we understand how it may interact with existing or development of eating disorders

doi: 10.1016/j.cell.2018.09.004 Summary Keywords inulin, short-chain fatty acids, intestinal immunity, intestinal microbiota, intestinal epithelial cells, intestinal immune cells Citation Sheng W, Ji G and Zhang L (2023) Immunomodulatory effects of inulin and its intestinal metabolites

What to Expect During the First Week After Your First Semaglutide GLP-1 Shot During the first week after your first semaglutide GLP-1 shot, you may begin to notice some initial changes in your appetite and digestion

Whole balance due up front, this product does not contain subscriptions or auto-renewals

Pancreatitis is a recognised class warning for GLP-1 receptor agonists, as noted in the prescribing information (SmPCs) for semaglutide and tirzepatide and in MHRA Drug Safety communications